SEARCH

SEARCH BY CITATION

References

  • 1
    Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395424.
  • 2
    Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 5205.
  • 3
    Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 7757.
  • 4
    Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 4549.
  • 5
    Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 8938.
  • 6
    Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 208993.
  • 7
    Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 16915.
  • 8
    Wahlberg TB, Blomback M, Magnusson D. Influence of sex, blood group, secretor character, smoking habits, acetylsalicylic acid, oral contraceptives, fasting and general health state on blood coagulation variables in randomly selected young adults. Haemostasis 1984; 14: 3129.
  • 9
    Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 145661.
  • 10
    Castaman G, Eikenboom JCJ, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 106570.
  • 11
    Casana P, Martinez F, Haya S, Espinos C, Aznar JA. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Br J Haematol 2001; 115: 692700.
  • 12
    Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmbeg L, Lethagen S, Pasi J, Hill F, Peake I. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 76673.
  • 13
    Rodeghiero F, Castaman G, Tosetto A, Battle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JCJ, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of von Willebrand disease type 1: an international, multicenter study. J Thromb Haemost 2005; 3: 261926.
  • 14
    Schneppenheim R, Plendl H, Budde U. Luminography-an alternative assay for detection of von Willebrand factor multimers. Thromb Haemost 1988; 60: 1336.
  • 15
    Zhang ZP, Deng LP, Blombäck M, Anvret M. Dinucleotide repeat polymorphism in the promotor region of the human von Willebrand factor gene (vWF gene). Hum Mol Genet 1992; 1: 780.
  • 16
    Van Amstel HK, Reitsma PH. Tetranucleotide repeat polymorphism in the vWF gene. Nucleic Acids Res 1990; 18: 4957.
  • 17
    Kimpton C, Walton A, Gill P. A further tetranucleotide repeat polymorphism in the vWF gene. Hum Mol Genet 1992; 1: 287.
  • 18
    Clark JM. Novel non-templated nucleotide addition-reactions catalyzed by procaryotic and eucaryotic DNA-polymerases. Nucleic Acids Res 1988; 16: 967786.
  • 19
    Brownstein MJ, Carpten JD, Smith JR. Modulation of non-templated nucleotide addition by tag DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 1996; 20: 10046.
  • 20
    Livak KJ. Allelic discrimination using fluorogenic probes and the 5nuclease assay. Genet Anal 1999; 14: 1439.
  • 21
    De Kok JB, Wiegerinck ETG, Giesendorf BAJ, Swinkels DW. Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Human Mutation 2002; 19: 5549.
  • 22
    Yip SP. Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood 2000; 95: 148792.
  • 23
    S.A.G.E. Statistical Analysis for Genetic Epidemiology. Cork, Ireland: Computer program package available from Statistical Solutions Ltd, 2004.
  • 24
    Faraway JJ. Distribution of the admixture test for the detection of linkage under heterogeneity. Genet Epidemiol 1993; 10: 7583.
  • 25
    Sham PC, Purcell S, Cherny SS, Abecasis GR. Powerful regression-based quantitative-trait linkage analysis of general pedigrees. Am J Hum Genet 2002; 71: 23853.
  • 26
    Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101: 154651.
  • 27
    Rosendaal FR, Bovill EG. Heritability of clotting factors and the revival of the prothrombotic state. Lancet 2002; 359: 6389.
  • 28
    Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1998; 37: 89101.
  • 29
    De Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet 2001; 357: 1015.
  • 30
    Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 2003; 89: 46874.
  • 31
    De Visser MC, Sandkuijl LA, Lensen RP, Vos HL, Rosendaal FR, Bertina RM. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci. J Thromb Haemost 2003; 1: 17716.
  • 32
    Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes B, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 1951427.